Charles Garner

Charles Garner joined Lung Therapeutics in 2018 as Chief Financial Officer. Mr. Garner brings over 20 years of investment banking, corporate finance, business development, and financial operational experience to Lung Therapeutics. Most recently, Mr. Garner was a life science industry consultant to private and public life sciences companies, providing financial and advisory services. Before this, Mr. Garner was Chief Financial Officer and Chief Business Officer for Recro Pharma, Inc., successfully leading the company's initial public offering and acquisition of select assets from Alkermes, plc. Mr. Garner began his professional career as a certified public accountant with PricewaterhouseCoopers and, while an investment banker for Deutsche Bank AG, raised or advised on over $8 billion of financial and advisory transactions for healthcare clients. Mr. Garner received his Bachelor's degree in Business Administration, high distinction, with a concentration in Accounting and Finance from the University of Michigan.